Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples